Daniel Sasca
Mainz, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Type I interferon-activated NK cells control polycythemia vera in vivo.
Journal: Blood
Published: March 09, 2026
Acute hemophagocytic lymphohistiocytosis in a patient treated for stone removal via percutaneous nephrolithotomy: a case report and literature review.
Journal: International journal of surgery case reports
Published: January 16, 2026
Therapeutic targeting of chromatin alterations in leukemia and solid tumors.
Journal: International journal of cancer
Published: November 25, 2024
MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients.
Journal: Annals of hematology
Published: May 20, 2024
Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma.
Journal: Leukemia
Published: January 18, 2023
Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax.
Journal: Haematologica
Published: September 25, 2022
Next generation epigenetic modulators to target myeloid neoplasms.
Journal: Current opinion in hematology
Published: July 16, 2021
Pandemic Spread of COVID-19 Mutant Variants Will Facilitate Next-generation Sequencing Capacities for Personalised Medicine in Urologic Oncology.
Journal: European urology
Published: February 12, 2021
Last Updated: 09/26/2026